Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2012: Clinical Research  

Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patients

Vincenzo Russo ADEF , Anna Rago BCE , Luisa Politano ADF , Andrea Antonio Papa BC , Federica Di Meo BC , Maria Giovanna Russo G , Paolo Golino G , Raffaele Calabrò G , Gerardo Nigro ADFG

DOI: 10.12659/MSM.883541

Med Sci Monit 2012; 18(11): CR643-647

0 Comments

Abstract

BACKGROUND: Sudden cardiac death (SCD) is common in patients with Emery-Dreifuss muscular dystrophy (EDMD) and is attributed to the development of life-threatening arrhythmias that occur in the presence of normal left ventricular systolic function. Heterogeneity of ventricular repolarization is considered to provide an electrophysiological substrate for malignant arrhythmias. QTc dispersion (QTc-D) and JTc dispersion (JTc-D) are electrocardiographic parameters indicative of heterogeneity of ventricular repolarization. The aim of our study was to evaluate the heterogeneity of ventricular repolarization in patients with Emery-Dreifuss muscular dystrophy with preserved systolic and diastolic cardiac function     

MATERIAL AND METHODS: The study involved 36 EDMD patients (age 20±12, 26 M) and 36 healthy subjects used as controls, matched for age and sex. Heart rate, QRS duration, maximum and minimum QT and JT interval, QTc-D and JTc-D measurements were performed.    

RESULTS:  Compared to the healthy control group, the EDMD group presented increased values of QTc-D (82.7±44.2 vs. 53.1±13.7; P=0,003) and JTc-D (73.6±32.3 vs. 60.4±11.1 ms; P=0.001). No correlation between QTc dispersion and ejection fraction (R=0.2, P=0.3) was found.    

CONCLUSIONS: Our study showed a significant increase of QTc-D and JTc-D in Emery-Dreifuss muscular dystrophy patients with preserved systolic and diastolic cardiac function.

Keywords: Muscular Dystrophy, Emery-Dreifuss - ultrasonography, Heart Ventricles - physiopathology, Electrocardiography, Case-Control Studies, Ventricular Function - physiology, young adult

Background

Emery-Dreifuss muscular dystrophy (EDMD) – first described by Emery and Dreifuss in 1966 – is a hereditary muscle disorder characterized by slowly progressive muscle wasting and weakness, with humero-peroneal distribution in the early stages, early contractures of the elbows, Achilles tendons and post-cervical muscles, and cardiomyopathy [1]. EDMD can be inherited either as an X-linked recessive disorder, caused by mutations in the STA gene that encodes the nuclear protein emerin on chomosome Xq28, or as an autosomal dominant trait caused by mutations in the gene encoding the nuclear protein lamin A/C (LMNA) on chromosome 1q21.2 [2]. Both patterns of inheritance result in the lack of the corresponding protein – emerin and/or lamin A/C – in muscle and skin nuclei [3]. Cardiomyopathy is the most serious and life-threatening clinical manifestation of the disease, and usually appears later compared with muscle impairment. Rhythm abnormalities commonly noted in the all forms of muscular dystrophies [4], especially in EDMD, include sinus node dysfunction, atrial flutter, atrial fibrillation, heart block, ventricular tachycardia, and ventricular fibrillation [5]. Sudden cardiac death (SCD) is common in patients with EDMD, and is attributed to the development of life-threatening arrhythmias which occur in the presence of normal left ventricular systolic function [6]. Thus, electrical abnormalities may be the earliest manifestation of the histopathological process conducive to the development of cardiomyopathy. The gene therapy [7,8], unfortunately, has not yet given the desired results up to this moment, so prevention of arrhythmic risk plays an important role in the current treatment of this rare form of muscular dystrophy. Assessment of the individual risk for sudden death in patients with Emery-Dreifuss muscular dystrophy remains a clinical challenge. SCD in EDMD patients has not received sufficient recognition in the literature, and its mechanism is potentially of great interest. QTc dispersion (QTc- D) and JTc dispersion (JTc- D) have been proposed as noninvasive methods to measure the heterogeneity of ventricular repolarization. Increased dispersion of ventricular repolarization is considered to provide an electrophysiological substrate for life-threatening ventricular arrhythmias [9,10] in several clinical conditions [11–16]. The aim of our study was to evaluate the heterogeneity of ventricular repolarization in EDMD by examining QTc-D and JTc-D, electrocardiographic parameters of spatial heterogeneity of ventricular repolarization, in EDMD patients with preserved systolic and diastolic function.

Material and Methods

STUDY POPULATION:

The study enrolled 36 EDMD subjects (26 men; age 20±12 years) recruited from the Cardiomyology and Medical Genetics Section of the 2nd University of Naples. Thirty-six age- and sex-matched non-EDMD healthy subjects were also recruited as controls. Exclusion criteria were: history of hypertension (systolic and diastolic blood pressure >140/90 mmHg), obesity, previous atrial fibrillation, electrolyte imbalance, valvular heart disease, diabetes mellitus or impaired glucose tolerance, chronic renal disease, thyroid disorders, chronic obstructive pulmonary disease, cardiomyopathy, connective tissue disorders, heart failure, left bundle branch block or atrioventricular conduction abnormalities on electrocardiogram (ECG), congenital heart disease, congestive heart failure, pericarditis, pulmonary embolism, sick sinus syndrome, and preexcitation syndromes. All patients were in sinus rhythm, and none of them was taking medications known to affect electrocardiographic intervals. All subjects gave their written informed consent.

STUDY PROTOCOL:

Medical history, physical examination, anthropometric evaluation, 12-lead surface ECG, 2D color Doppler echocardiogram and ECG Holter monitoring were performed in the study population. The patients were rested for at least 15 min before cardiovascular assessments, including electrocardiography and echocardiography.

ELECTROCARDIOGRAPHIC MEASUREMENTS:

All subjects underwent a routine standard 12-lead body surface ECG, recorded at a paper speed of 50 mm/s and gain of 10 mm/mV in the supine position, and were breathing freely but not allowed to speak during the ECG recording. To avoid diurnal variations, we generally performed the ECG recordings at the same time (9:00 A.M. to 10:00 A.M.). The analysis was performed by 1 investigator, without knowledge of subjects’ clinic status. ECGs were transferred to a personal computer by an optical scanner and then magnified 400 times by Adobe Photoshop software (Adobe Systems Inc., San Jose, CA). QRS duration, QT interval and JT interval were evaluated with the use of computer software (Configurable Measurement System) using digitizer 34180 (Calcomp, Anaheim, CA, USA). The variability of the measurements was 0.32±5 ms, which was not statistically significant. The standard correlation was 95% (95% CI 25.63 to 6.31). In each electrocardiogram lead, the analysis included 3 consecutive heart cycles, wherever possible. Leads were excluded from analysis when the end of the T-wave was not clearly distinguishable, or the signal quality was too poor for analysis. The QRS interval was measured from the start of the Q wave, or, in the absence of the Q wave, from the start of R wave to the end of S (to its return to the isoelectric line). The QT interval was measured from the initial deflection of the QRS complex to the end of the T wave (to the point where the T wave returned to the isoelectric line). When U wave was present, the QT was measured to the nadir of the curve between the T and U waves. If the end of the T wave could not be reliably determined, or if the T waves were isoelectric or of very low amplitude, measurements were not done and these leads were excluded from analysis. The JT interval was derived by subtracting the QRS duration from the QT interval [17]. QTd was the difference between the maximal and the minimal QT value in all leads [18]. The difference between the maximal and the minimal JT value in all leads was defined as JTd. All measurements were corrected for heart rate using Bazett’s formula (QTc=QT/√RR; JTc =JT/√RR) [19].

ECHOCARDIOGRAPHIC EVALUATION:

Images were gathered with a standard ultrasound machine with a 3.5-MHz phased-array probe (M3S). All the echocardiographic studies were digitally stored, and all the measurements were performed off-line by 2 independent observers who were blinded to the clinical status of the subjects. Selected parameters were measured according to the American Society of Echocardiography recommendations [20] in M-mode from parasternal long-axis view: left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), interventricular septum thickness (IVST), left ventricular posterior wall thickness (LVPT). LV mass (LVM) was calculated by using Devereux’s formula, and was indexed for body surface area and height [21]. Ejection fraction was measured using a modified Simpson’s biplane method. Each representative value was obtained from the average of 3 measurements. Pulsed-wave Doppler examination was performed to obtain the following indexes of LV diastolic function: peak mitral inflow velocities at early (E) and late (A) diastole and E/A ratio. Average values of these indexes obtained from 5 consecutive cardiac cycles were used for analysis.

STATISTICAL ANALYSIS:

Continuous variables are expressed as mean ± standard deviation (SD). The data in each group has a Gaussian distribution. Statistical analysis was performed using Student’s t test. P values <0.05 were considered to be statistically significant. Pearson’s simple correlation allowed studying the association between 2 variables. Analyses were performed using the statistical package SPSS 11.0 software for Windows SPSS Inc. (Chicago, IL, USA).

Results

CLINICAL AND ECHOCARDIOGRAPHIC PARAMETERS:

Clinical and echocardiographic characteristics of the study population are summarized in Table 1. The healthy control group did not significantly differ from EDMD group in BMI, heart rate and blood pressure (BP). No significant differences in LVPWEDT (7.2±0.8 vs. 5.9±1.2 mm, P=0.3), IVSEDT (7.5±1.2 vs. 6.3±0.8 mm, P=0.4), LVEDD (49.4±5.1 vs. 43.4±4.5 mm, P=0.3), LVESD (34.4±5.7 vs. 32.2±4.8 mm, P=0.4), LVM/H (35.7±10 vs. 32.5±9 g/m 2.7, P=0.3), left ventricle fractional shortening (FS; 34.8±4.1 vs. 32.3±4.2%, P=0.2) and ejection fraction (EF 64.6±5.1 vs. 63.4±8.1%, P=0.1) between the 2 groups were observed. These data indicate compensated normal systolic function in the EDMD group. Compared with controls, the EDMD group did not show significant E wave (82.3±16.5 vs. 92.4±10.8 cm/s; P=0.2), A wave (57.9±12.5 vs. 52.03±9.72 cm/s; P=0.3) and E/A ratio (1.5±0.4 vs. 1.8±0.38; P=0.3) variations. These data indicate normal diastolic function in the EDMD group.

QTC AND JTC DISPERSION:

Electrocardiographic characteristics of the study population are shown in Table 2. Compared to the healthy control group, the EDMD group presented increased values of QTc-D (82.7±44.2 vs. 53.1±13.7; P=0.003) and JTc-D (73.6±32.3 vs. 60.4±11.1 ms; P=0.001) (Figure 1). Absolute value of intraobserver variability of QTc and JTc dispersion measurement was 7±4 ms and 4±2 ms, respectively. No statistically significant correlation between QTc-D, JTc-D, BMI (P=0.2), LVM (P=0.3) and ejection fraction (P=0.1) was found. No statistically significant differences in QTc-D (92.5±39.3 vs. 70.6±48.7 ms, P=0.4) and JTc-D (61.73±16.46 vs. 64.72±14,12 ms, P=0.4) between the laminopathy EDMD subgroup and the emerinopathy EDMD subgroup were found.

Discussion

PREVIOUS STUDIES:

Previous experimental studies have shown a slight decrease of heart rates, with significant prolongations of PQ, QRS and QT intervals compared with control recordings in conscious, restrained LMNA−/− mice ECG recordings. These ECG changes resemble some aspects of the ECG records from humans with EDMD (28). To our knowledge, no information is present in literature about QTc and JTc dispersion in EDMD patients with normal systolic and diastolic function. It is known that sudden cardiac death has a high incidence in patients carrying STA and Lamin A/C gene mutations. SCD is attributed to the development of life-threatening arrhythmias, probably related to the specific histopathological pattern characterized by diffuse fibrosis and fatty acid infiltration [29,30].

MAIN FINDINGS:

Studying the QTc-D and JTc-D in EDMD patients without systolic or diastolic dysfunction, and without other clinically appreciable diseases, might have offered the unique clinical opportunity to exclude the influence of possible comorbidities on the evaluation of heterogeneity of ventricular repolarization in this population. Our data showed that the electrocardiographic parameters, proposed to estimate the ventricular repolarization heterogeneity (QTc-D, JTc-D), were significantly increased in EDMD patients when compared with age and sex-matched healthy controls. The significant increase in heterogeneity of ventricular repolarization parameters in EDMD patients suggests that cardiac diffuse fibrosis and fatty acid infiltration per se influences regional dispersion of repolarization, even when systolic and diastolic cardiac function are preserved.

LIMITATIONS:

The small number of patients included is certainly a limitation, and a more extensive study is needed to confirm these findings. QT interval and JT interval were made on 12-lead ECGs, with the use of computer software and digitizer by an experienced cardiologist observer. However, there remains an absence of indisputable, generally accepted criteria for the definition of the end of T interval, implying some degree of possible error in the measurements. The 12-lead surface ECG, compared with body surface mapping or vector cardiography, gives an incomplete picture of cardiac electric activity, so QTd could not be a true manifestation of local heterogeneity of repolarization.

Conclusions

Our study showed a significant increase of QTc-D and JTc-D, electrocardiographic parameters considered to reflect the heterogeneity of the ventricular repolarization, in EDMD patients with normal systolic and diastolic function. Our results suggest the hypothesis that diffuse fibrosis and fatty acid infiltration, in the absence of systolic and diastolic dysfunction, may increase ventricular electrical instability and produce the electrophysiological substrate for ventricular malignant tachyarrhythmias and sudden cardiac death. Further studies are necessary to assess the effective relationship between QTc and JTc dispersion and sudden death in EDMD patients.

References

1. Emery AE, Dreifuss FE, Unusual type of benign X-linked muscular dystrophy: J Neurol Neurosurg Psychiatr, 1966; 29; 338-42, pmid: 5969090

2. Nigro V, Bruni P, Ciccodicola A, SSCP detection of novel mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a small C-terminal region required for emerin function: Hum Mol Genet, 1995; 4(10); 2003-4, pmid: 8595433

3. Mora M, Cartegni L, Di Blasi C, X-linked Emery-Dreifuss muscular dystrophy can be diagnosed from skin biopsy or blood sample: Ann Neurol, 1997; 42(2); 249-53, pmid: 9266737

4. Dello Russo A, Mangiola F, Della Bella P, Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study: J Cardiovasc Med (Hagerstown), 2009; 10(1); 51-58, pmid: 19708226

5. Stucki C, Christen S, Gerber A, Cardiopathy in a patient with Emery-Dreifuss muscular dystrophy: Journal of Clinical and Basic Cardiology, 2000; 3; 145-46

6. D’Andrea A, Salerno G, Scarafile R, Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy: Pacing Clin Electrophysiol, 2009; 32(8); 1017-29, pmid: 19659622

7. Rotundo IL, Faraso S, De Leonibus E, Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy: PLoS One, 2011; 6(9); e24729, pmid: 21931833

8. Lancioni A, Rotundo IL, Kobayashi YM, Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex: Hum Mol Genet, 2011; 20(23); 4644-54, pmid: 21890494

9. Merx W, Yoon MS, Han J, The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation: Am Heart J, 1977; 94; 603-10, pmid: 910699

10. Kuo CS, Munakata K, Reddy CP, Characteristics and possible mechanisms of ventricular arrhythmia dependent on the dispersion of action potential durations: Circulation, 1983; 67; 1356-57, pmid: 6851031

11. Buja G, Miorelli M, Turrini P, Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death: Am J Cardiol, 1993; 72; 973-76, pmid: 8213559

12. Barr CS, Nass A, Freeman M, QT dispersion and sudden unexpected death in chronic heart failure: Lancet, 1994; 343; 327-29, pmid: 7905146

13. Higham PD, Furniss SS, Campbell RW, QT dispersion and components of the QT interval in ischaemia and infarction: Br Heart J, 1995; 73; 32-36, pmid: 7888257

14. Paventi S, Bevilacqua U, Parafati MA, QT dispersion and early arrhythmic risk during acute myocardial infarction: Angiology, 1999; 50; 209-15, pmid: 10088800

15. Russo V, Rago A, Pannone B, Dispersion of repolarization and beta talassemia major: the prognostic role of QT and JT dispersion for identifying the high risk patients for sudden death: Eur J Haematol, 2011; 86(4); 324-31, pmid: 21255082

16. Nigro G, Russo V, Di Salvo G, Increased heterogenity of ventricular repolarization in obese nonhypertensive children: Pacing Clin Electrophysiol, 2010; 33(12); 1533-39, pmid: 20946307

17. Fuller MS, Sandor G, Punske P, Estimates of repolarization dispersion from electrocardiographic measurements: Circulation, 2000; 102; 685-91, pmid: 10931810

18. de Bruyne MC, Hoes AW, Kors JA, QTc dispersion predicts cardiac mortality in the elderly. The Rotterdam Study: Circulation, 1998; 97; 467-72, pmid: 9490242

19. Bazzett J, Regression formulas to fit QT/RR patterns. An analysis of time relations of electrocardiograms: Heart, 1920; 7; 353-67

20. Picard MH, Adams D, Bierig SM, American Society of Echocardiography recommendations for quality echocardiography laboratory operations: J Am Soc Echocardiogr, 2011; 24(1); 1-10, pmid: 21172594

21. Devereux RB, Alonso RD, Lutas EM, Echocardiographic assessment of left ventricular ipertrophy: comparison to necropsy finding: Amer J Cardiol, 1986; 57; 450-58, pmid: 2936235

22. Ichkhan K, Molnar J, Somberg J, Relation of left ventricularmass and QT dispersion in patients with systematic hypertension: Am J Cardiol, 1997; 79; 508-11, pmid: 9052362

23. Wei K, Dorian P, Newman , Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus: J Am Coll Cardiol, 1995; 26; 859-63, pmid: 7560609

24. Day CP, McComb JM, Campbell RWF, QT dispersion: an indication of arrhythmia in risk patients with long QT intervals: Br Heart J, 1990; 63; 342-44, pmid: 2375895

25. Russo V, Ammendola E, De Crescenzo I, Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients: Obesity Surgery, 2007; 17; 857-65, pmid: 17894142

26. Vassallo JA, Cassidy DM, Kindwall KE, Non-uniform recovery of excitability in the left ventricle: Circulation, 1988; 78; 1365-72, pmid: 3191591

27. Merx W, Yoon MS, Han J, The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation: Am Heart J, 1977; 94; 603-10, pmid: 910699

28. Grattan MJ, Kondo C, Thurston S, Skeletal and cardiac muscle defects in a murine model of Emery Dreifuss muscular dystrophy. Faculty of Medicine, University of Calgary, Calgary Canada: Novartis Found Symp, 2005; 264; 118-33, pmid: 15773751

29. Sakata K, Shimizu M, Ino H, High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene: Circulation, 2005; 111(25); 3352-58, pmid: 15967842

30. Becane HM, Bonne G, Varnous S, High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation: Pacing Clin Electrophysiol, 2000; 23; 1661-66, pmid: 11138304

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750